Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
1 study found for:    19420195 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
International Safety and Efficacy Study of Aztreonam for Inhalation Solution (AZLI) in Cystic Fibrosis Patients With P. Aeruginosa
Condition: Cystic Fibrosis
Interventions: Drug: AZLI 75 mg three times a day (TID);   Drug: Placebo three times a day (TID)

Study has passed its completion date and status has not been verified in more than two years.